| Primary |
| Product Used For Unknown Indication |
29.5% |
| Hypertension |
29.4% |
| Cardiac Failure |
7.4% |
| Cardiac Failure Chronic |
5.1% |
| Diabetes Mellitus |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Prophylaxis |
3.0% |
| Type 2 Diabetes Mellitus |
2.2% |
| Gastritis |
1.9% |
| Hyperlipidaemia |
1.7% |
| Hyperuricaemia |
1.7% |
| Constipation |
1.7% |
| Atrial Fibrillation |
1.5% |
| Insomnia |
1.5% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Essential Hypertension |
1.1% |
| Myocardial Infarction |
1.1% |
| Migraine Prophylaxis |
1.0% |
| Benign Prostatic Hyperplasia |
0.9% |
|
| Interstitial Lung Disease |
15.4% |
| Renal Failure Acute |
8.8% |
| Rhabdomyolysis |
8.1% |
| Hypotension |
5.9% |
| Oligohydramnios |
5.9% |
| Renal Impairment |
5.1% |
| Hyperkalaemia |
4.4% |
| Orthostatic Hypotension |
4.4% |
| Renal Failure |
4.4% |
| Toxic Skin Eruption |
4.4% |
| Hypoglycaemia |
3.7% |
| Loss Of Consciousness |
3.7% |
| Skull Malformation |
3.7% |
| Swollen Tongue |
3.7% |
| Syncope |
3.7% |
| Dehydration |
2.9% |
| Hypertensive Crisis |
2.9% |
| Liver Disorder |
2.9% |
| Pregnancy |
2.9% |
| Presyncope |
2.9% |
|
| Secondary |
| Hypertension |
31.9% |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
12.6% |
| Diabetes Mellitus |
4.0% |
| Cardiac Failure |
3.5% |
| Hyperlipidaemia |
2.9% |
| Type 2 Diabetes Mellitus |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Rash |
2.0% |
| Prophylaxis |
1.9% |
| Cardiac Failure Chronic |
1.9% |
| Maternal Exposure Timing Unspecified |
1.5% |
| Hyperuricaemia |
1.4% |
| Angina Pectoris |
1.3% |
| Gastritis |
1.3% |
| Atrial Fibrillation |
1.2% |
| Cardiovascular Event Prophylaxis |
1.1% |
| Osteoarthritis |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Constipation |
1.0% |
|
| Renal Failure Acute |
14.0% |
| Interstitial Lung Disease |
8.7% |
| Rhabdomyolysis |
7.9% |
| Liver Disorder |
6.6% |
| Coronary Artery Occlusion |
5.0% |
| Dizziness |
5.0% |
| Orthostatic Hypotension |
5.0% |
| Vomiting |
5.0% |
| Oligohydramnios |
4.5% |
| Renal Failure |
4.5% |
| Hyperkalaemia |
4.1% |
| Loss Of Consciousness |
4.1% |
| Pneumonia |
3.7% |
| Swollen Tongue |
3.7% |
| Syncope |
3.7% |
| Abnormal Dreams |
3.3% |
| Cholestasis |
2.9% |
| Malaise |
2.9% |
| Septic Shock |
2.9% |
| Angioedema |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Hypertension |
21.5% |
| Drug Use For Unknown Indication |
13.0% |
| Rheumatoid Arthritis |
7.4% |
| Prophylaxis |
5.4% |
| Diabetes Mellitus |
3.5% |
| Hepatitis C |
2.6% |
| Atrial Fibrillation |
2.0% |
| Osteoporosis |
2.0% |
| Pain |
1.9% |
| Constipation |
1.9% |
| Hyperlipidaemia |
1.7% |
| Depression |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Insomnia |
1.6% |
| Multiple Myeloma |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Metastatic Renal Cell Carcinoma |
1.3% |
| Cardiac Failure |
1.3% |
| Gastritis |
1.1% |
|
| Vomiting |
9.1% |
| Renal Failure Acute |
7.2% |
| Pyrexia |
7.1% |
| Malaise |
6.6% |
| Renal Failure |
6.6% |
| Rhabdomyolysis |
5.8% |
| Nausea |
4.9% |
| Rash |
4.9% |
| Renal Impairment |
4.8% |
| Hepatic Function Abnormal |
4.6% |
| Pneumonia |
4.3% |
| Death |
4.1% |
| Weight Decreased |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Anaemia |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Blood Creatinine Increased |
3.7% |
| Thrombocytopenia |
3.7% |
| Cerebral Haemorrhage |
3.5% |
| Myalgia |
3.5% |
|
| Interacting |
| Product Used For Unknown Indication |
55.6% |
| Hypertension |
13.5% |
| Atrial Fibrillation |
5.8% |
| Drug Use For Unknown Indication |
3.5% |
| Cardiac Failure |
2.9% |
| Hyperuricaemia |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Angina Pectoris |
1.8% |
| Arteriosclerosis Obliterans |
1.8% |
| Gastritis |
1.8% |
| Nasopharyngitis |
1.8% |
| Onychomycosis |
1.2% |
| Pain |
1.2% |
| Arthralgia |
0.9% |
| Dyslipidaemia |
0.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
| Pulmonary Hypertension |
0.9% |
| Cardiovascular Event Prophylaxis |
0.6% |
| Hiv Infection |
0.6% |
| Muscle Spasms |
0.6% |
|
| Ventricular Tachycardia |
15.8% |
| Renal Failure Acute |
13.2% |
| Drug Interaction |
10.5% |
| Shock |
7.9% |
| Vestibular Disorder |
7.9% |
| Drug Prescribing Error |
5.3% |
| Transaminases Increased |
5.3% |
| Abasia |
2.6% |
| Aortic Stenosis |
2.6% |
| Atrioventricular Block Second Degree |
2.6% |
| Cardiac Arrest |
2.6% |
| Condition Aggravated |
2.6% |
| Dementia |
2.6% |
| Hypertensive Crisis |
2.6% |
| Nail Discolouration |
2.6% |
| Paraesthesia |
2.6% |
| Prothrombin Time Prolonged |
2.6% |
| Renal Impairment |
2.6% |
| Rhabdomyolysis |
2.6% |
| Sepsis |
2.6% |
|
